Arlington Trust’s CONMED CNMD Stock Holding History

Arlington Trust’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4	Closed	-$208	–	598
2025 Q2	$208	Buy	+4	New	+$220	﹤0.01%	686
2024 Q1	–	Sell	-49	Closed	-$5.37K	–	565
2023 Q4	$5.37K	Buy	+49	New	+$5.07K	﹤0.01%	469

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Arlington Trust's CNMD Position: Q3 2025 in Review

Arlington Trust sold out of CONMED (CNMD) in Q3 2025, closing a stake of 4 shares — an estimated $208 sold.

Arlington Trust first reported a position in CNMD in Q4 2023 and held it in 2 quarters. The position peaked at $5.37K in Q4 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

Arlington Trust reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
Arlington Trust sold 4 CONMED shares in Q3 2025, an estimated $208.
Arlington Trust first reported a position in CONMED in Q4 2023 and held it in 2 quarters.
Arlington Trust's CONMED position peaked at $5.37K in Q4 2023.
273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Arlington Trust's 13F filing for Q3 2025, filed 28 Oct 2025.